Haematology Immersion Program 2025
Educational Program on Multiple Myeloma by J&J Malaysia
Meet the Multiple Myeloma Experts
With collaboration between J & J and MSH (By INVITATION ONLY)
ASH CRTI Asia Pacific Region 2026 Kuala Lumpur
*Last Chance to Apply for the ASH CRTI in the Asia-Pacific Region!*
Applications are due on August 14
Two weeks left to apply for the ASH Clinical Research Training Institute in Asia-Pacific (CRTI-APAC),
taking place
in Kuala Lumpur, Malaysia on April 13-15, 2026!
Fellows or early- to mid-career hematology faculty in the Asia-Pacific region, this program is your opportunity to network with peers and advance your clinical research capabilities. Don't miss out, apply now!
ASH covers all travel and lodging, and application costs!
Eligible Applicants:
-
Be a clinician (e.g., MD, nurse, psychologist) practicing in hematology
-
Be fluent in written and spoken English
-
Be within 15 years of their first faculty appointment
-
Live and work in an eligible Asia-Pacific country
-
Not have previously received a CRTI-APAC award
Apply By August 14! Applicants will be notified in October 2025.
MSH SEP 2025 FELLOWSHIP PART 2 EXAM
Malaysian Society of Haematology – Part 2 Viva Exam (2025)
The Part 2 Viva Examination will be held on 18th September 2025
Venue: Department of Internal Medicine, Sultan Ahmad Shah Medical Centre @ IIUM, Kuantan.
Eligibility Criteria:
-
Completion of 3 years of Haematology training
-
Obtained supervisor’s approval and report
-
Passed Part 1 examination
-
Completed dissertation successfully or have a publication
Important Deadlines:
-
Application form submission: by 18th August 2025
-
Logbook and thesis submission to the training committee: by 18th August 2025
-
Exam registration fee (RM 200) must be paid before the exam date
HEMON Update 13-15 June 2025
On behalf of the Organizing Committee of the Semarang Hematology Medical Oncology (HEMON) Update 2025, we kindly invite your organization to participate in and support the promotion of this upcoming scientific event, which will be held in Semarang, Indonesia, from June 13–15, 2025, in a hybrid format (onsite and online).
This event will include symposia, plenary lectures, workshops, and case discussions, highlighting the latest advances in cancer care, targeted therapy, immunotherapy, and the integration of digital and precision medicine in clinical oncology.
Further information on the program and registration is available in the attached brochure and